glp-1 for perimenopause Agonists in Perimenopause: Unique Risks and Potential Opportunities A thoughtful approach to GLP-1
Description
But nearly four in 10 (38%) say they took the drugs solely to lose weight
We have a lot more information toward the first question, and theres almost nothing toward the second question
Psychiatry 28 , 19021918 (2023)
Zhou B, Caudal A, Tang X, Chavez JD, McMillen TS, Keller A, et al
This study was a randomised control cross-over trial of 11 individuals who were assigned to either a KD or standard diet for 3-weeks and then switched after a wash-out period
